Cargando…
Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies
INTRODUCTION: Lack of medication conversion from intravenous to oral contributes to increased risk of infection, delayed discharges and higher medication costs. At our institution, intravenous to oral medication conversion rate was 76% with missed opportunity for conversion of 37%. The goal of the p...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011893/ https://www.ncbi.nlm.nih.gov/pubmed/31986120 http://dx.doi.org/10.1136/bmjoq-2019-000804 |
_version_ | 1783496148639547392 |
---|---|
author | Downen, Julie Jaeger, Cassie |
author_facet | Downen, Julie Jaeger, Cassie |
author_sort | Downen, Julie |
collection | PubMed |
description | INTRODUCTION: Lack of medication conversion from intravenous to oral contributes to increased risk of infection, delayed discharges and higher medication costs. At our institution, intravenous to oral medication conversion rate was 76% with missed opportunity for conversion of 37%. The goal of the project was to reduce the percent of missed opportunities for intravenous to oral conversion for applicable medications. METHODS: A pharmacy-driven intravenous to oral policy and procedure was implemented. To identify potential opportunities, a patient worklist of applicable intravenous to oral medications was created for pharmacy review in real time. An intravenous to oral conversion order was implemented in the computerised provider order entry. ‘Convert to oral’ was added as an option in the electronic medication request and highlighted reminders were added to the electronic medication administration record for eligible medications. RESULTS: After improvements, the missed opportunity rate for intravenous to oral conversion decreased from 37% (19/51) to 21% (24/113) (p=0.04, two-proportion test), a 43% improvement. The trend in intravenous to oral conversion rate increased from 76% (39/51) to 85% (171/201) and severity adjusted length of stay was reduced from 8.1 days to 6.4 days post improvements (p<0.001, t-test). |
format | Online Article Text |
id | pubmed-7011893 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-70118932020-02-25 Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies Downen, Julie Jaeger, Cassie BMJ Open Qual Quality Improvement Report INTRODUCTION: Lack of medication conversion from intravenous to oral contributes to increased risk of infection, delayed discharges and higher medication costs. At our institution, intravenous to oral medication conversion rate was 76% with missed opportunity for conversion of 37%. The goal of the project was to reduce the percent of missed opportunities for intravenous to oral conversion for applicable medications. METHODS: A pharmacy-driven intravenous to oral policy and procedure was implemented. To identify potential opportunities, a patient worklist of applicable intravenous to oral medications was created for pharmacy review in real time. An intravenous to oral conversion order was implemented in the computerised provider order entry. ‘Convert to oral’ was added as an option in the electronic medication request and highlighted reminders were added to the electronic medication administration record for eligible medications. RESULTS: After improvements, the missed opportunity rate for intravenous to oral conversion decreased from 37% (19/51) to 21% (24/113) (p=0.04, two-proportion test), a 43% improvement. The trend in intravenous to oral conversion rate increased from 76% (39/51) to 85% (171/201) and severity adjusted length of stay was reduced from 8.1 days to 6.4 days post improvements (p<0.001, t-test). BMJ Publishing Group 2020-01-20 /pmc/articles/PMC7011893/ /pubmed/31986120 http://dx.doi.org/10.1136/bmjoq-2019-000804 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Quality Improvement Report Downen, Julie Jaeger, Cassie Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies |
title | Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies |
title_full | Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies |
title_fullStr | Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies |
title_full_unstemmed | Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies |
title_short | Quality improvement of intravenous to oral medication conversion using Lean Six Sigma methodologies |
title_sort | quality improvement of intravenous to oral medication conversion using lean six sigma methodologies |
topic | Quality Improvement Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011893/ https://www.ncbi.nlm.nih.gov/pubmed/31986120 http://dx.doi.org/10.1136/bmjoq-2019-000804 |
work_keys_str_mv | AT downenjulie qualityimprovementofintravenoustooralmedicationconversionusingleansixsigmamethodologies AT jaegercassie qualityimprovementofintravenoustooralmedicationconversionusingleansixsigmamethodologies |